Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lela Bitar

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Health and Quality of Life Outcomes|December 11, 2020
Quality of life 10 years after cardiac surgery in adults: a long-term follow-up studyJosip Vincelj, Lela Bitar
Expert Opinion on Biological Therapy|September 17, 2024
Long-term progression-free survival in non-small cell lung cancer patients: a spotlight on bevacizumab and its biosimilarsFran Seiwerth, Lela Bitar, Miroslav Samaržija, et al.
Journal of Thoracic Disease|January 15, 2021
Immunotherapy for thymomaMarko Jakopovic, Lela Bitar, Fran Seiwerth, et al.
International Journal of Molecular Sciences|December 11, 2022
The Interplay of Lung Cancer, COVID-19, and VaccinesDragan Trivanović, Željka Peršurić, Andrea Agaj, et al.
Journal of Oncology|December 30, 2020
Real-World Safety and Efficacy of Nivolumab in Advanced Squamous and Nonsquamous Non-Small-Cell Lung Cancer: A Retrospective Cohort Study in Croatia, Hungary, and MaltaEduard Vrdoljak, Marko Jakopović, Lajos Geczi, et al.
Radiology and Oncology|September 4, 2023
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysisLidija Ljubicic, Urska Janzic, Mojca Unk, et al.
Nature Biotechnology|January 22, 2025
Quantum-computing-enhanced algorithm unveils potential KRAS inhibitorsMohammad Ghazi Vakili, Christoph Gorgulla, Jamie Snider, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Health and Quality of Life Outcomes|December 11, 2020
Quality of life 10 years after cardiac surgery in adults: a long-term follow-up studyJosip Vincelj, Lela Bitar
Expert Opinion on Biological Therapy|September 17, 2024
Long-term progression-free survival in non-small cell lung cancer patients: a spotlight on bevacizumab and its biosimilarsFran Seiwerth, Lela Bitar, Miroslav Samaržija, et al.
Journal of Thoracic Disease|January 15, 2021
Immunotherapy for thymomaMarko Jakopovic, Lela Bitar, Fran Seiwerth, et al.
International Journal of Molecular Sciences|December 11, 2022
The Interplay of Lung Cancer, COVID-19, and VaccinesDragan Trivanović, Željka Peršurić, Andrea Agaj, et al.
Journal of Oncology|December 30, 2020
Real-World Safety and Efficacy of Nivolumab in Advanced Squamous and Nonsquamous Non-Small-Cell Lung Cancer: A Retrospective Cohort Study in Croatia, Hungary, and MaltaEduard Vrdoljak, Marko Jakopović, Lajos Geczi, et al.
Radiology and Oncology|September 4, 2023
Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysisLidija Ljubicic, Urska Janzic, Mojca Unk, et al.
Nature Biotechnology|January 22, 2025
Quantum-computing-enhanced algorithm unveils potential KRAS inhibitorsMohammad Ghazi Vakili, Christoph Gorgulla, Jamie Snider, et al.
Pageof 1